# Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration

> **NCT00280514** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 20 (estimated)

## Conditions studied

- Abscess
- Cysts

## Interventions

- **DRUG:** cefpirome and moxifloxacin administration

## Key facts

- **NCT ID:** NCT00280514
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00280514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00280514, "Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00280514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*